|1.||Tomavo, Stanislas: 3 articles (12/2015 - 03/2003)|
|2.||Chen, Yuan-Tsong: 3 articles (02/2011 - 03/2008)|
|3.||Kang, Peter B: 2 articles (12/2010 - 03/2008)|
|4.||Bali, Deeksha S: 2 articles (12/2010 - 03/2008)|
|5.||Cassandrini, D: 2 articles (07/2007 - 09/2004)|
|6.||Minetti, C: 2 articles (07/2007 - 09/2004)|
|7.||Assereto, S: 2 articles (07/2007 - 09/2004)|
|8.||Bruno, C: 2 articles (07/2007 - 09/2004)|
|9.||Coppin, Alexandra: 2 articles (02/2005 - 03/2003)|
|10.||Gooley, Paul R: 1 article (12/2015)|
|1.||Glycogen Storage Disease (Glycogenosis)
05/01/1988 - "The muscle biopsy showed a glycogenosis with deposits of amylopectin-like material. "
11/01/1995 - "Failure of liver transplantation to diminish cardiac deposits of amylopectin and leukocyte inclusions in type IV glycogen storage disease."
03/18/1993 - "Histopathological examination revealed that the cardiac deposits of amylopectin in the patients with glycogen storage disease and the lymph-node deposits of glucocerebroside in the patient with Gaucher's disease were dramatically reduced after transplantation. "
03/18/1993 - "Liver transplantation for type IV glycogen storage disease (branching-enzyme deficiency) results in the resorption of extrahepatic deposits of amylopectin, but the mechanism of resorption is not known. "
06/01/2009 - "Our objective is to evaluate the hemostatic efficacy of a newly modified amylopectin powder in a model of severe extremity arterial hemorrhage. "
06/01/2009 - "Modified amylopectin powder demonstrates the ability to control major vascular bleeding in a lethal arterial injury model during a 3-hour period."
|3.||Gaucher Disease (Gaucher's Disease)
|4.||Muscular Diseases (Myopathy)
01/01/1981 - "Polysaccharide (amylopectin-like) storage myopathy histochemical ultrastructural and biochemical studies."
01/01/1992 - "Twelve patients with polysaccharide amylopectin-like storage myopathy have previously been reported. "
01/01/1992 - "[Polysaccharide amylopectin-type storage myopathy]."
01/01/1993 - "Amylopectin was found in many extrahepatic tissues prior to surgery, but cardiopathy and skeletal myopathy have not developed after transplantation. "
09/01/2008 - "We describe a 15-year-old boy and his 19-year-old sister with progressive dilated cardiomyopathy and mild non-progressive proximal lower limb myopathy, secondary to the accumulation of amylopectin-like fibrillar glycogen, (polyglucosan) bodies, in heart and skeletal muscle. "
|5.||Body Weight (Weight, Body)
01/01/1988 - "Both orosensory and postingestive factors may contribute to the differential food intake and body weight gains produced by the different types (Polycose vs. amylopectin) and forms (gel vs. powder) of carbohydrates."
01/01/1988 - "Over the 30-day test periods, carbohydrate intake, total food intake, and body weight gain were greater with the Polycose than with the amylopectin, and greater with the gel form than with the powder form of the carbohydrates. "
10/01/2009 - "This study comprised 2 experiments that tested the hypothesis that a high-amylose starch diet (AMO) would improve body weight and glycemic control relative to a high-amylopectin starch diet (AMN) in rats with diet-induced obesity. "
07/01/1997 - "Male rats were fed either commercial cornstarch, dextrose, modified soluble potato (70-75% amylopectin) starch, or modified soluble amylomaize-7 (70% amylose) starch for 4 wk. Body weights did not differ among the groups. "
|3.||1,4-alpha-Glucan Branching Enzyme (Glycogen Branching Enzyme)
|1.||Transplantation (Transplant Recipients)